# Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-BGB-3111 in Healthy Males

> **NCT04163783** · PHASE1 · COMPLETED · sponsor: **BeiGene** · enrollment: 6 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** [14C]-BGB-3111
- **DRUG:** BGB-3111

## Key facts

- **NCT ID:** NCT04163783
- **Lead sponsor:** BeiGene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-29
- **Primary completion:** 2017-04-18
- **Final completion:** 2017-04-18
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2019-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04163783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04163783, "Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-BGB-3111 in Healthy Males". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04163783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*